US › Healthcare

Incannex Healthcare Inc. (IXHL)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.24-1.32%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Revenue YoY

-100.0%

Net profit

$-6.3M

EPS

$-0.14

EPS estimate

$0.13

EPS came in at -0.14 against a street estimate of 0.13 — a miss of 207.7%.

Key statistics

Market cap

$28.5M

Forward P/E

3.8

P/B

0.42

Book value

$5.37

EPS (TTM)

$-1.66

52-week high

$14.91

52-week low

$2.16

50-day MA

$3.08

200-day MA

$4.03

Beta

2.84

Analyst view

Analysts rate Incannex Healthcare Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $18.87.

Shareholding

Insiders

9.12%

Institutions

3.64%

Largest institutional holders

Fund	Stake
LPL Financial Corp	1.18%
Millennium Management LLC	0.76%
Jane Street Group LLC	0.62%
AdvisorShares Investments, LLC	0.49%
Susquehanna International Group, LLP	0.23%
Commonwealth Equity Services, LLC	0.11%
Citadel Advisors Llc	0.08%
Advisor Group Holdings, Inc.	0.05%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Incannex Healthcare Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.